David Harrich
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Turning defects into defenses: the potential and challenges of defective viral genome-based antiviral strategies.
Journal: Microbiology and molecular biology reviews : MMBR
Published: May 06, 2026
Harnessing defective interfering particles and lipid nanoparticles for effective delivery of an anti-dengue virus RNA therapy.
Journal: Molecular therapy. Nucleic acids
Published: June 13, 2024
Low back pain and osteoarthritis pain: a perspective of estrogen.
Journal: Bone research
Published: December 14, 2022
Defective Interfering Particles with Broad-Acting Antiviral Activity for Dengue, Zika, Yellow Fever, Respiratory Syncytial and SARS-CoV-2 Virus Infection.
Journal: Microbiology spectrum
Published: November 29, 2022
Assessing the Binding of Venoms from Aquatic Elapids to the Nicotinic Acetylcholine Receptor Orthosteric Site of Different Prey Models.
Journal: International journal of molecular sciences
Published: September 07, 2020
The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
Journal: Reviews in medical virology
Published: August 12, 2020
Dengue virus-free defective interfering particles have potent and broad anti-dengue virus activity.
Journal: Communications biology
Published: June 24, 2020
Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure.
Journal: Viruses
Published: February 28, 2020
Evolutionary Interpretations of Nicotinic Acetylcholine Receptor Targeting Venom Effects by a Clade of Asian Viperidae Snakes.
Journal: Neurotoxicity research
Published: January 23, 2020
Last Updated: 09/26/2026